Health Catalyst, Inc. (HCAT) vs LifeMD, Inc. (LFMD)

A side-by-side comparison of Health Catalyst, Inc. and LifeMD, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — HCAT vs LFMD

growth of $100 · dividends reinvested · last 7y
HCAT -95.5% (-35.8%/yr)LFMD +318.5% (+22.7%/yr)LFMD compounded faster over this window
Log scale — wide-divergence pair
1101001k10kStart $100202120232025$4$418
HCAT LFMD

HCAT vs LFMD: by the numbers

  • •LFMD is the larger company ($135M vs $132M market cap).
  • •Both run net losses; LFMD's is the smaller (-10.40% vs -90.61% net margin).
  • •LFMD grew revenue faster over the past five years (26.00% vs 6.24% CAGR).

Metrics side by side

Valuation

MetricHCATLFMD
P/S ratio0.450.66
P/B ratio1.3016.91
EV / EBITDA74.61N/A
FCF yield9.93%N/A

Profitability

MetricHCATLFMD
Gross margin33.47%85.91%
Operating margin-11.60%-9.35%
Net margin-90.61%-10.40%
ROE-262.64%-266.86%
ROIC-21.42%-143.97%

Growth (annualized)

MetricHCATLFMD
Revenue CAGR (5Y)6.24%26.00%
Total return CAGR (5Y)-48.35%-14.66%

Frequently asked

Which has grown faster, HCAT or LFMD?
Over the past five years, LFMD grew revenue faster — HCAT at a 6.24% CAGR versus LFMD at 26.00%.
How have HCAT and LFMD total returns compared?
Over the past 5 years, HCAT delivered -48.35% and LFMD delivered -14.66% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.